Onconic Therapeutics
₩11,800
0
-₩590-4.76% 06:30 Today
Statistics
Day High
12,270
Day Low
11,700
52W High
28,900
52W Low
8,790
Volume
103,827
Avg. Volume
511,686
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 17Expected
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise, primarily dedicated to the discovery and advancement of novel therapeutic solutions. Its research and development initiatives principally focus on creating new medications for acid-related ailments and various oncological conditions. This company was established on May 7, 2020, and maintains its principal office in Seoul, South Korea.
Show More
CEO
John Kim
Employees
38
Country
South Korea
ISIN
KR7476060009
Listings
0 Comments
Share your thoughts
FAQs
What is Onconic Therapeutics stock price today?▼
The current price of 476060.KQ is ₩11,800 KRW — it has decreased by -4.76% in the past 24 hours. Watch Onconic Therapeutics stock price performance more closely on the chart.
What is Onconic Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Onconic Therapeutics stocks are traded under the ticker 476060.KQ.
Is Onconic Therapeutics stock price growing?▼
476060.KQ stock has fallen by -7.6% compared to the previous week, the month change is a -24.89% fall, over the last year Onconic Therapeutics has showed a -20.38% decrease.
When is the next Onconic Therapeutics earnings date?▼
Onconic Therapeutics is going to release the next earnings report on November 17, 2026.
How many employees does Onconic Therapeutics have?▼
As of November 3, 2026, the company has 38 employees.
In which sector is Onconic Therapeutics located?▼
Onconic Therapeutics operates in the Health & Wellness sector.
When did Onconic Therapeutics complete a stock split?▼
The last stock split for Onconic Therapeutics was on October 10, 2025 with a ratio of 3:1.
Where is Onconic Therapeutics headquartered?▼
Onconic Therapeutics is headquartered in Seoul, South Korea.